More Business Wire
View Older Stories View Newer Stories-
Calibrate Unveils Fourth Annual Results Report Showcasing Sustained Weight Loss and Metabolic Health Improvements
-
Wolfspeed Completes $200 Million At-The-Market Equity Offering
-
Genius Sports Announces Pricing of Public Offering
-
Prospect Medical Holdings, Inc. Receives Court Approval of “First Day” Motions
-
Energetic Capital Awarded Prestigious InnSure Innovation Prize for Energy Transition Insurance Solution
-
Medidata Expands Leadership Team to Drive Patient-Centered and Customer-Focused Innovation
-
InterPayments Appoints Former Discover Financial Services CEO and President, Roger Hochschild, to Its Board of Directors
-
DPS Announces CaseMail.AI Expansion to Microsoft Clients via Azure Marketplace and AppSource
-
Belle Expands In-Home and Virtual Chronic Care Capabilities, Creating Access for More than 50 Million Polychronic Medicare Members with Ongoing Care Management Needs
-
Teledyne Announces Fourth Quarter and Full Year 2024 Earnings Webcast Details
-
Attentive Hosts Exclusive Event with Google During National Retail Federation Week as RCS Messaging Takes Off in 2025
-
Stellex Capital Management Acquires Electrical Services Provider ICS Holding
-
Despite Highly Manual Processes, Only 33% of Auditors Say They Use AI, Compared to 76% of Accounting and Finance Professionals
-
Citigroup Reports Fourth Quarter and Full-Year 2024 Results
-
OneSpan to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025
-
EverDriven Reports a 167.4% Increase in the Number of McKinney-Vento Students Served Since 2020
-
Colossal Secures $200M in Series C Funding From TWG Global on the Back of Numerous World’s First Scientific Breakthroughs on Path to De-Extinction
-
CrowdStrike Launches Insider Risk Services to Combat Insider Threats
-
Energy Vault and NuCube Energy Form Strategic Partnership to Power AI Data Centers with Nuclear Microreactors, Offering Flexible Baseload, Energy Storage and Grid Services Capabilities
-
ENVISION Trial Results Published in the February Issue of The Journal of Urology Highlight UGN-102 Achievement of 82.3% Duration of Response at 12 Months Paving the Way for the Potential First FDA-App
-
Marathon Asset Management Provides $154.5M Loan to Refinance Premier Senior Living Communities
-
CareView Communications Announces New Business Agreement With Mercy Medical Center in Cedar Rapids, IA
-
TPG to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Investor Call
-
Vellum Publishes State of AI Development Report: AI Adoption to Increase in 2025 - Despite Lingering Challenges
-
Integrity Reforestation and Agoke Development LP (ADLP) Launch Major Initiative to Restore Wildfire-Impacted Land and Caribou Habitat in Ontario’s Ogoki Forest
-
Avnet to Report Second Quarter Fiscal Year 2025 Earnings on January 29
-
Tour24 Promotes Dorota Firek to Chief Marketing Officer
-
Amogy Raises $56 Million to Bolster Commercialization of Pioneering Ammonia-to-Power Solutions
-
Thoughtworks Looking Glass Report Highlights the Importance of the Next Phase of AI Adoption in 2025
-
Slate Grocery REIT Announces Distribution for the Month of January 2025
-
Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators
-
Solstice Gold Defines Large-Scale IP Geophysical Anomalies at Strathy Gold Project, Receives OJEP Grant
-
Allianz Risk Barometer 2025: Cyber Top Business Risk as Climate Change Hits Record High
-
Infrastructure Capital Advisors Adds to Its Lineup of Innovative Income-Generating Solutions with the Launch of the Infrastructure Capital Bond Income ETF (BNDS)
-
OS Therapies Announces Phase 2b Clinical Trial of OST-HER2 Achieves Primary Endpoint with Statistical Significance in the Prevention of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma
-
Inflammasome Therapeutics Announces Topline 3-month Data from a Clinical Trial of its First-in-Class Dual Inflammasome Inhibitor, K8, in Geographic Atrophy, Demonstrating Rapid, Substantial and Signif
-
Zai Lab Announces Positive Topline Results for TIVDAK in the China Subpopulation of the Global Phase 3 innovaTV 301 Trial in Patients with Recurrent or Metastatic Cervical Cancer
-
Realbotix CES 2025 Update
-
Verastem Oncology Names Matthew E. Ros as Chief Operating Officer
-
D-Wave and Carahsoft Partner to Expand Distribution of Quantum Computing Solutions to the Public Sector
-
Vestis Announces Date for Fiscal First Quarter 2025 Earnings Results
-
Monro, Inc. to Report Third Quarter Fiscal 2025 Earnings on January 29, 2025
-
FourKites Introduces Intelligent Control Tower with Real-Time Data, Digital Twins and AI-Powered Digital Workforce
-
Advanced Drainage Systems to Announce Third Quarter Fiscal Year 2025 Results on February 6, 2025
-
Corient Acquires Multi-Family Office Business of Geller, Expanding U.S. Wealth Management Presence and Deepening Family Office Capabilities
-
WiSA Technologies Announces Upcoming Investor Conferences
-
SkyWater Announces ThermaView℠ Solutions to Strengthen Domestic Support for High Performance Thermal Imaging
-
NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan
-
Wells Fargo Reports Fourth Quarter 2024 Financial Results
-
FiscalNote Unveils PolicyNote: The Future of AI-Powered Policy Solutions
